Ke-da X. Yu
270 Dong An Road
Shanghai, 200032, China
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 131 publications
ASO Visual Abstract: Omission of Axillary Surgery in Patients with Negative Axillary Evaluation Integrated with LymphPET: A Prospective Clinical Study.
Journal: Annals of surgical oncology
Published: March 30, 2026
Spatial proteogenomic profiling uncovers sensitization strategies for antibody-drug conjugate in HER2-positive breast cancer.
Journal: Cell reports. Medicine
Published: February 25, 2026
Metabolic drivers of genome instability in cancer: mechanisms and therapeutic opportunities.
Journal: Experimental hematology & oncology
Published: February 19, 2026
Precision neoadjuvant treatment with AI-assisted subtyping in HR+/HER2-breast cancer: A randomized, phase 2 trial FASCINATE-N.
Journal: Cell reports. Medicine
Published: February 04, 2026
Integrated genomic profiling identifies predictive biomarkers for neoadjuvant therapy response in Chinese breast cancer patients.
Journal: Cancer letters
Published: February 03, 2026
Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trial.
Journal: BMJ (Clinical research ed.)
Published: December 23, 2025
Omission of Axillary Surgery in Patients with Negative Axillary Evaluation Integrated with LymphPET: A Prospective Clinical Study.
Journal: Annals of surgical oncology
Published: October 30, 2025
Multi-omics analysis reveals comprehensive aberrant protein and phosphorylation characteristics in breast cancer and paired metastatic lymph nodes.
Journal: Protein & cell
Published: August 13, 2025
Multi-omics Analysis Reveals Comprehensive Aberrant Protein and Phosphorylation Characteristics in Breast Cancer and Paired Metastatic Lymph Nodes.
Journal: Protein & cell
Published: August 13, 2025
Single-cell multi-omics analysis reveals two molecular subtypes of human male breast cancer with distinct neuroendocrine and immune characteristics.
Journal: Journal of advanced research
Published: June 23, 2025
Last Updated: 09/26/2026